Evaluating disease severity in chronic pain patients with and without fibromyalgia

A comparison of the symptom impact questionnaire and the polysymptomatic distress scale

Ronald Friend, Robert (Rob) Bennett

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    Objective. To compare the relative effectiveness of the Polysymptomatic Distress Scale (PSD) with the Symptom Impact Questionnaire (SIQR), the disease-neutral revision of the updated Fibromyalgia Impact Questionnaire (FIQR), in their ability to assess disease activity in patients with rheumatic disorders both with and without fibromyalgia (FM). Methods. The study included 321 patients from 8 clinical practices with some 16 different chronic pain disorders. Disease severity was assessed by the Medical Outcomes Study Short Form-36 (SF-36). Univariate analyses were used to assess the magnitude of PSD and SIQR correlations with SF-36 subscales. Hierarchical stepwise regression was used to evaluate the unique contribution of the PSD and SIQR to the SF-36. Random forest regression probed the relative importance of the SIQR and PSD components as predictors of SF-36. Results. The correlations with the SF-36 subscales were significantly higher for the SIQR (0.48 to 0.78) than the PSD (0.29 to 0.56; p <0.001). Stepwise regression revealed that the SIQR was contributing additional unique variance on SF-36 subscales, which was not the case for the PSD. Random forest regression showed SIQR Function, Symptoms, and Global Impact subscales were more important predictors of SF-36 than the PSD. The single SIQR pain item contributed 55% of SF-36 pain variance compared to 23% with the 19-point WPI (the Widespread Pain Index component of PSD). Conclusion. The SIQR, the disease-neutral revision of the updated FIQ, has several important advantages over the PSD in the evaluation of disease severity in chronic pain disorders.

    Original languageEnglish (US)
    Pages (from-to)2404-2411
    Number of pages8
    JournalJournal of Rheumatology
    Volume42
    Issue number12
    DOIs
    StatePublished - Dec 1 2015

    Fingerprint

    Fibromyalgia
    Chronic Pain
    Somatoform Disorders
    Pain
    Surveys and Questionnaires
    Aptitude
    Outcome Assessment (Health Care)

    Keywords

    • Fibromyalgia
    • Fibromyalgia impact questionnaire
    • Medical outcomes study short form-36
    • Polysymptomatic distress
    • Polysymptomatic distress scale
    • Symptom impact questionnaire

    ASJC Scopus subject areas

    • Rheumatology
    • Immunology
    • Immunology and Allergy

    Cite this

    Evaluating disease severity in chronic pain patients with and without fibromyalgia : A comparison of the symptom impact questionnaire and the polysymptomatic distress scale. / Friend, Ronald; Bennett, Robert (Rob).

    In: Journal of Rheumatology, Vol. 42, No. 12, 01.12.2015, p. 2404-2411.

    Research output: Contribution to journalArticle

    @article{36611a07054a4acabf80138aa2ca4a8e,
    title = "Evaluating disease severity in chronic pain patients with and without fibromyalgia: A comparison of the symptom impact questionnaire and the polysymptomatic distress scale",
    abstract = "Objective. To compare the relative effectiveness of the Polysymptomatic Distress Scale (PSD) with the Symptom Impact Questionnaire (SIQR), the disease-neutral revision of the updated Fibromyalgia Impact Questionnaire (FIQR), in their ability to assess disease activity in patients with rheumatic disorders both with and without fibromyalgia (FM). Methods. The study included 321 patients from 8 clinical practices with some 16 different chronic pain disorders. Disease severity was assessed by the Medical Outcomes Study Short Form-36 (SF-36). Univariate analyses were used to assess the magnitude of PSD and SIQR correlations with SF-36 subscales. Hierarchical stepwise regression was used to evaluate the unique contribution of the PSD and SIQR to the SF-36. Random forest regression probed the relative importance of the SIQR and PSD components as predictors of SF-36. Results. The correlations with the SF-36 subscales were significantly higher for the SIQR (0.48 to 0.78) than the PSD (0.29 to 0.56; p <0.001). Stepwise regression revealed that the SIQR was contributing additional unique variance on SF-36 subscales, which was not the case for the PSD. Random forest regression showed SIQR Function, Symptoms, and Global Impact subscales were more important predictors of SF-36 than the PSD. The single SIQR pain item contributed 55{\%} of SF-36 pain variance compared to 23{\%} with the 19-point WPI (the Widespread Pain Index component of PSD). Conclusion. The SIQR, the disease-neutral revision of the updated FIQ, has several important advantages over the PSD in the evaluation of disease severity in chronic pain disorders.",
    keywords = "Fibromyalgia, Fibromyalgia impact questionnaire, Medical outcomes study short form-36, Polysymptomatic distress, Polysymptomatic distress scale, Symptom impact questionnaire",
    author = "Ronald Friend and Bennett, {Robert (Rob)}",
    year = "2015",
    month = "12",
    day = "1",
    doi = "10.3899/jrheum.150443",
    language = "English (US)",
    volume = "42",
    pages = "2404--2411",
    journal = "Journal of Rheumatology",
    issn = "0315-162X",
    publisher = "Journal of Rheumatology",
    number = "12",

    }

    TY - JOUR

    T1 - Evaluating disease severity in chronic pain patients with and without fibromyalgia

    T2 - A comparison of the symptom impact questionnaire and the polysymptomatic distress scale

    AU - Friend, Ronald

    AU - Bennett, Robert (Rob)

    PY - 2015/12/1

    Y1 - 2015/12/1

    N2 - Objective. To compare the relative effectiveness of the Polysymptomatic Distress Scale (PSD) with the Symptom Impact Questionnaire (SIQR), the disease-neutral revision of the updated Fibromyalgia Impact Questionnaire (FIQR), in their ability to assess disease activity in patients with rheumatic disorders both with and without fibromyalgia (FM). Methods. The study included 321 patients from 8 clinical practices with some 16 different chronic pain disorders. Disease severity was assessed by the Medical Outcomes Study Short Form-36 (SF-36). Univariate analyses were used to assess the magnitude of PSD and SIQR correlations with SF-36 subscales. Hierarchical stepwise regression was used to evaluate the unique contribution of the PSD and SIQR to the SF-36. Random forest regression probed the relative importance of the SIQR and PSD components as predictors of SF-36. Results. The correlations with the SF-36 subscales were significantly higher for the SIQR (0.48 to 0.78) than the PSD (0.29 to 0.56; p <0.001). Stepwise regression revealed that the SIQR was contributing additional unique variance on SF-36 subscales, which was not the case for the PSD. Random forest regression showed SIQR Function, Symptoms, and Global Impact subscales were more important predictors of SF-36 than the PSD. The single SIQR pain item contributed 55% of SF-36 pain variance compared to 23% with the 19-point WPI (the Widespread Pain Index component of PSD). Conclusion. The SIQR, the disease-neutral revision of the updated FIQ, has several important advantages over the PSD in the evaluation of disease severity in chronic pain disorders.

    AB - Objective. To compare the relative effectiveness of the Polysymptomatic Distress Scale (PSD) with the Symptom Impact Questionnaire (SIQR), the disease-neutral revision of the updated Fibromyalgia Impact Questionnaire (FIQR), in their ability to assess disease activity in patients with rheumatic disorders both with and without fibromyalgia (FM). Methods. The study included 321 patients from 8 clinical practices with some 16 different chronic pain disorders. Disease severity was assessed by the Medical Outcomes Study Short Form-36 (SF-36). Univariate analyses were used to assess the magnitude of PSD and SIQR correlations with SF-36 subscales. Hierarchical stepwise regression was used to evaluate the unique contribution of the PSD and SIQR to the SF-36. Random forest regression probed the relative importance of the SIQR and PSD components as predictors of SF-36. Results. The correlations with the SF-36 subscales were significantly higher for the SIQR (0.48 to 0.78) than the PSD (0.29 to 0.56; p <0.001). Stepwise regression revealed that the SIQR was contributing additional unique variance on SF-36 subscales, which was not the case for the PSD. Random forest regression showed SIQR Function, Symptoms, and Global Impact subscales were more important predictors of SF-36 than the PSD. The single SIQR pain item contributed 55% of SF-36 pain variance compared to 23% with the 19-point WPI (the Widespread Pain Index component of PSD). Conclusion. The SIQR, the disease-neutral revision of the updated FIQ, has several important advantages over the PSD in the evaluation of disease severity in chronic pain disorders.

    KW - Fibromyalgia

    KW - Fibromyalgia impact questionnaire

    KW - Medical outcomes study short form-36

    KW - Polysymptomatic distress

    KW - Polysymptomatic distress scale

    KW - Symptom impact questionnaire

    UR - http://www.scopus.com/inward/record.url?scp=84948844688&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84948844688&partnerID=8YFLogxK

    U2 - 10.3899/jrheum.150443

    DO - 10.3899/jrheum.150443

    M3 - Article

    VL - 42

    SP - 2404

    EP - 2411

    JO - Journal of Rheumatology

    JF - Journal of Rheumatology

    SN - 0315-162X

    IS - 12

    ER -